Biological networks are complex, and effective therapies may require combinations of drugs to overcome redundancies, feedback mechanisms, or drug resistance. Such screening is challenging because
Highlights •Anti-cancer drugs have variable efficacy within patient populations •Drug combinations give each patient more chances that one drug could be effective •Clinical efficacy of